Cargando…
Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study
BACKGROUND: Insulin resistance and adiponectin are markers of cardio-metabolic disease and associated with adverse cardiovascular outcomes. The present study examined whether preoperative insulin resistance or adiponectin were associated with short- and long-term adverse outcomes in non-diabetic pat...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009968/ https://www.ncbi.nlm.nih.gov/pubmed/21156037 http://dx.doi.org/10.1186/1749-8090-5-129 |
_version_ | 1782194751566512128 |
---|---|
author | Mikkelsen, Martin M Hansen, Troels K Gjedsted, Jakob Andersen, Niels H Christensen, Thomas D Hjortdal, Vibeke E Johnsen, Søren P |
author_facet | Mikkelsen, Martin M Hansen, Troels K Gjedsted, Jakob Andersen, Niels H Christensen, Thomas D Hjortdal, Vibeke E Johnsen, Søren P |
author_sort | Mikkelsen, Martin M |
collection | PubMed |
description | BACKGROUND: Insulin resistance and adiponectin are markers of cardio-metabolic disease and associated with adverse cardiovascular outcomes. The present study examined whether preoperative insulin resistance or adiponectin were associated with short- and long-term adverse outcomes in non-diabetic patients undergoing elective cardiac surgery. METHODS: In a prospective study, we assessed insulin resistance and adiponectin levels from preoperative fasting blood samples in 836 patients undergoing cardiac surgery. Population-based medical registries were used for postoperative follow-up. Outcomes included all-cause death, myocardial infarction or percutaneous coronary intervention, stroke, re-exploration, renal failure, and infections. The ability of insulin resistance and adiponectin to predict clinical adverse outcomes was examined using receiver operating characteristics. RESULTS: Neither insulin resistance nor adiponectin were statistically significantly associated with 30-day mortality, but adiponectin was associated with an increased 31-365-day mortality (adjusted odds ratio 2.9 [95% confidence interval 1.3-6.4]) comparing the upper quartile with the three lower quartiles. Insulin resistance was a poor predictor of adverse outcomes. In contrast, the predictive accuracy of adiponectin (area under curve 0.75 [95% confidence interval 0.65-0.85]) was similar to that of the EuroSCORE (area under curve 0.75 [95% confidence interval 0.67-0.83]) and a model including adiponectin and the EuroSCORE had an area under curve of 0.78 [95% confidence interval 0.68-0.88] concerning 31-365-day mortality. CONCLUSIONS: Elevated adiponectin levels, but not insulin resistance, were associated with increased mortality and appear to be a strong predictor of long-term mortality. Additional studies are warranted to further clarify the possible clinical role of adiponectin assessment in cardiac surgery. TRIAL REGISTRATION: The Danish Data Protection Agency; reference no. 2007-41-1514. |
format | Text |
id | pubmed-3009968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-30099682011-01-10 Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study Mikkelsen, Martin M Hansen, Troels K Gjedsted, Jakob Andersen, Niels H Christensen, Thomas D Hjortdal, Vibeke E Johnsen, Søren P J Cardiothorac Surg Research Article BACKGROUND: Insulin resistance and adiponectin are markers of cardio-metabolic disease and associated with adverse cardiovascular outcomes. The present study examined whether preoperative insulin resistance or adiponectin were associated with short- and long-term adverse outcomes in non-diabetic patients undergoing elective cardiac surgery. METHODS: In a prospective study, we assessed insulin resistance and adiponectin levels from preoperative fasting blood samples in 836 patients undergoing cardiac surgery. Population-based medical registries were used for postoperative follow-up. Outcomes included all-cause death, myocardial infarction or percutaneous coronary intervention, stroke, re-exploration, renal failure, and infections. The ability of insulin resistance and adiponectin to predict clinical adverse outcomes was examined using receiver operating characteristics. RESULTS: Neither insulin resistance nor adiponectin were statistically significantly associated with 30-day mortality, but adiponectin was associated with an increased 31-365-day mortality (adjusted odds ratio 2.9 [95% confidence interval 1.3-6.4]) comparing the upper quartile with the three lower quartiles. Insulin resistance was a poor predictor of adverse outcomes. In contrast, the predictive accuracy of adiponectin (area under curve 0.75 [95% confidence interval 0.65-0.85]) was similar to that of the EuroSCORE (area under curve 0.75 [95% confidence interval 0.67-0.83]) and a model including adiponectin and the EuroSCORE had an area under curve of 0.78 [95% confidence interval 0.68-0.88] concerning 31-365-day mortality. CONCLUSIONS: Elevated adiponectin levels, but not insulin resistance, were associated with increased mortality and appear to be a strong predictor of long-term mortality. Additional studies are warranted to further clarify the possible clinical role of adiponectin assessment in cardiac surgery. TRIAL REGISTRATION: The Danish Data Protection Agency; reference no. 2007-41-1514. BioMed Central 2010-12-14 /pmc/articles/PMC3009968/ /pubmed/21156037 http://dx.doi.org/10.1186/1749-8090-5-129 Text en Copyright ©2010 Mikkelsen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mikkelsen, Martin M Hansen, Troels K Gjedsted, Jakob Andersen, Niels H Christensen, Thomas D Hjortdal, Vibeke E Johnsen, Søren P Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
title | Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
title_full | Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
title_fullStr | Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
title_full_unstemmed | Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
title_short | Insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
title_sort | insulin resistance, adiponectin and adverse outcomes following elective cardiac surgery: a prospective follow-up study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009968/ https://www.ncbi.nlm.nih.gov/pubmed/21156037 http://dx.doi.org/10.1186/1749-8090-5-129 |
work_keys_str_mv | AT mikkelsenmartinm insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy AT hansentroelsk insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy AT gjedstedjakob insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy AT andersennielsh insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy AT christensenthomasd insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy AT hjortdalvibekee insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy AT johnsensørenp insulinresistanceadiponectinandadverseoutcomesfollowingelectivecardiacsurgeryaprospectivefollowupstudy |